Logo

Nectar Lifesciences Ltd. Share Price

Nectar Lifesciences Ltd. (INR)38.52-0.8   (-2%)

Exchange ScripsBSE532649NSENECLIFEISININE023H01027

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Nectar Lifesciences Ltd. Performance

Market performance
Open price39.51
High39.51
Volumes424494
Prev Close38.52
Low38.52
Closing date2025-01-24
Historical performance
1 Year High56.50
3 Year High56.50
5 Year High56.50
1 Year Low26.15
3 Year Low14.50
5 Year Low7.10

Nectar Lifesciences Ltd. Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
882
Face Value
Face Value (₹)
1
P/E Ratio
P/E Ratio
172.97
Dividend Yield
Dividend Yield
N/A

Nectar Lifesciences Ltd. Investment Returns

1 Year
8.4%
3 Years
18.9%
5 Years
171.3%
10 Years
5.1%

Nectar Lifesciences Ltd. Technicals

IndicatorsValueSignal
5-DMA39.62Bearish
10-DMA39.29Bearish
20-DMA39.22Bearish
50-DMA37.56Bullish
100-DMA39.22Bearish
200-DMA36.01Bullish

Shareholding Pattern

FieldDec-2024Sep-2024Jun-2024Mar-2024Dec-2023
Promoters32222
Foreign Investors---------------
Domestic Investors32222
Public Investors6947966738582275994360758
Government11111

Nectar Lifesciences Ltd. Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income243531113114
Operating Profit1759106116991128
Interest9698947881120
Depreciation607591570603
Profit Before Tax183-424341-848
Consolidated Net Profit50-242250-733
Adjusted EPS----11-3

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital224224224224
Total Reserves10468104221065510396
Minority Interest------------
Total Non-Current Liabilities1415213129631264
Total Liabilities21836216862388023758
Capital Work in Progress658778851986
Total Assets21836216862388023758

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities22471337950214
Cash Flow from Investing Activities-170517166-286
Cash Flow from Financing Activitie-2054-1856-1194115
Net Cash Inflow / Outflow22-2-7742
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 172.97.
  • 3Y Stock Price CAGR of the stock is 6.2.
  • The stock has a beta of 0.9.
  • In the last financial year, the company had an EBITDA of ₹1759 Million.
  • The company generated revenue of ₹16841 Million in the previous financial year.

Nectar Lifesciences Ltd.

38.52-0.8   (-2%)

Investment Amount: ₹ 3610
Current Value: ₹ 3852
Performance: 6.7%
P/L: ₹ 242
Top Gainers
SymbolChange%
MPSLTD2463.6(13%)
CGCL200.6(10%)
JYOTISTRUC24.81(10%)
PILITA16.02(9%)
TRF410.75(8%)
Top Losers
SymbolChange%
CYIENT1344.9(-23%)
JWL422.45(-11%)
TEJASNET993.75(-9%)
ARVSMART706.45(-9%)
RAMANEWS15.14(-9%)
SOLARA622.15(-8%)
RAJRATAN430.8(-8%)
SILGO30.19(-8%)
Similar stocks

Medico Remedies Ltd.

47.8

71.87

December 24 - January 24

Alivus Life Sciences Ltd.

19.9

1149.25

December 24 - January 24

Biocon Ltd.

12.7

388.25

December 24 - January 24

Indegene Ltd.

11.7

658.8

December 24 - January 24

Zota Health Care Ltd.

11.4

922.05

December 24 - January 24

Astrazeneca Pharma India Ltd.

7.9

6928.6

December 24 - January 24

Laurus Labs Ltd.

6.3

602.65

December 24 - January 24

Aarti Pharmalabs Ltd.

6.2

621.3

December 24 - January 24

Announcing Stock of the Month!

Stock of the Month
Stock of the Month